Yi Dai

1.4k total citations
53 papers, 1.1k citations indexed

About

Yi Dai is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Yi Dai has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 13 papers in Cancer Research and 8 papers in Pathology and Forensic Medicine. Recurrent topics in Yi Dai's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Endometriosis Research and Treatment (5 papers). Yi Dai is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Endometriosis Research and Treatment (5 papers). Yi Dai collaborates with scholars based in China, United States and Hong Kong. Yi Dai's co-authors include Feng Liu, Wenbin Guo, Muliang Jiang, Changqing Xiao, Liling Long, Jian Zhang, Yukui Yan, Minghua Hu, Xiaochun Jiang and Yaxian Wang and has published in prestigious journals such as PLoS ONE, Chemical Communications and Journal of Agricultural and Food Chemistry.

In The Last Decade

Yi Dai

49 papers receiving 1.0k citations

Peers

Yi Dai

RNMI

ONCOL

Sarah Song Australia

Mo Zhang China

Yaxuan Wang China

Juntao Ke China

Giovanny R. Pinto Brazil

Yun Zhu China

Jie Yuan China

Fenfen Sun China

Anahita Bhathena United States

Sarah Song Australia

Yi Dai

431 ×0.8

180 ×0.5

60 ×0.2

54 ×0.4

RNMI

315 ×2.9

ONCOL

Citations per year, relative to Yi Dai Yi Dai (= 1×) peers Sarah Song

Countries citing papers authored by Yi Dai

Since Specialization

Citations

This map shows the geographic impact of Yi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Dai more than expected).

Fields of papers citing papers by Yi Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Dai. The network helps show where Yi Dai may publish in the future.

Co-authorship network of co-authors of Yi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Dai. A scholar is included among the top collaborators of Yi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Dai. Yi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dai, Yi, et al.. (2025). Towards Fully Disaggregated Recommendation Model Serving. 38–45.

Li, Xiaoyan, Yi Dai, Jinghua Shi, et al.. (2025). Global, regional, and national burdens of endometriosis from 1990 to 2021: a trend analysis. Frontiers in Medicine. 12. 1562196–1562196.

Dai, Yi, et al.. (2024). The clinical efficacy of a daratumumab-based regimen in relapsed/refractory acute leukemia: a single-center experience. Annals of Hematology. 103(10). 4057–4063. 2 indexed citations

Dong, Yimin, Yiping Huang, Yaqing Liu, et al.. (2024). Nrf2 induces angiogenesis in spinal cystic echinococcosis by activating autophagy via regulating oxidative stress. Biochemical Pharmacology. 226. 116337–116337.

Li, Hui, et al.. (2023). IRF2BPL gene variants with dystonia: one new Chinese case report. BMC Neurology. 23(1). 32–32. 4 indexed citations

Wu, Yushi, Yi Dai, Junji Zhang, et al.. (2022). The clinical features and long-term surgical outcomes of different types of abdominal wall endometriosis. Archives of Gynecology and Obstetrics. 307(1). 163–168. 7 indexed citations

Shi, Jinghua, Xiaoyan Li, Yi Dai, et al.. (2022). Oral gonadotropin-releasing hormone antagonists for treating endometriosis-associated pain: a systematic review and network meta-analysis. Fertility and Sterility. 118(6). 1102–1116. 13 indexed citations

Zhou, Yan, Shuai Chen, Yi Dai, et al.. (2022). Sinomenine attenuated dextran sulfate sodium-induced inflammatory responses by promoting 14-3-3θ protein and inhibiting NF-κB signaling. Journal of Ethnopharmacology. 303. 116037–116037. 8 indexed citations

Wei, Jie, Yi Dai, Xun Huang, et al.. (2021). Dipetidyl peptidase-4 and transferrin receptor serve as prognostic biomarkers for acute myeloid leukemia. Annals of Translational Medicine. 9(17). 1381–1381. 15 indexed citations

10.

Jin, Ming, Rong Cai, Yi Dai, et al.. (2020). Arsenic trioxide enhances the chemotherapeutic efficiency of cisplatin in cholangiocarcinoma cells via inhibiting the 14-3-3ε-mediated survival mechanism. Cell Death Discovery. 6(1). 92–92. 9 indexed citations

11.

Wu, Ke, et al.. (2019). GSK923295 as a potential antihepatocellular carcinoma agent causing delay on liver regeneration after partial hepatectomy. Chinese Medical Journal. 132(3). 311–318. 5 indexed citations

12.

Shan, Wenqi, Ye Yang, Ming Jin, et al.. (2019). Reversal of sorafenib resistance in hepatocellular carcinoma: epigenetically regulated disruption of 14-3-3η/hypoxia-inducible factor-1α. Cell Death Discovery. 5(1). 120–120. 47 indexed citations

13.

Dai, Yi, et al.. (2019). <p>Silencing Of hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation Of microRNA-214-3p/EZH2 Axis</p>. Cancer Management and Research. Volume 11. 9133–9143. 35 indexed citations

14.

Dai, Yi, Chi Zhang, Ye Yang, et al.. (2018). Arsenic trioxide reverses the chemoresistance in hepatocellular carcinoma: a targeted intervention of 14–3-3η/NF-κB feedback loop. Journal of Experimental & Clinical Cancer Research. 37(1). 321–321. 41 indexed citations

15.

Zhao, Hongbo, et al.. (2018). ABCC10 Plays a Significant Role in the Transport of Gefitinib and Contributes to Acquired Resistance to Gefitinib in NSCLC. Frontiers in Pharmacology. 9. 1312–1312. 37 indexed citations

16.

Chu, Chao, Yi Dai, Jianjun Mu, et al.. (2017). Associations of risk factors in childhood with arterial stiffness 26 years later. Journal of Hypertension. 35(Supplement 1). S10–S15. 33 indexed citations

17.

Lü, Ming, Yi Dai, Chi Zhang, et al.. (2017). The Attenuation of 14-3-3ζ is Involved in the Caffeic Acid-Blocked Lipopolysaccharide-Stimulated Inflammatory Response in RAW264.7 Macrophages. Inflammation. 40(5). 1753–1760. 23 indexed citations

18.

Tang, Chengwu, Jian Shen, Wenming Feng, et al.. (2016). Combination Therapy of Radiofrequency Ablation and Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma. Medicine. 95(20). e3754–e3754. 36 indexed citations

19.

Song, Yan, Qinji Su, Muliang Jiang, et al.. (2015). Abnormal regional homogeneity and its correlations with personality in first-episode, treatment-naive somatization disorder. International Journal of Psychophysiology. 97(2). 108–112. 22 indexed citations

20.

Zheng, Honghao, et al.. (2007). Anti-tumor Activity of the Compound Recipe Radix Sophorae Flavescentis for Injection in vivo and in vitro. 亚洲传统医药. 2(1). 19–22. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact